rAAV capsid mutants eliminate leaky expression from DNA donor template for homologous recombination
Chen Ling,Chenghui Yu,Cong Wang,Ming Yang,Hengbin Yang,Keying Yang,Yun He,Yajie Shen,Shiyi Tang,Xiaomin Yu,Zhengjun Zhou,Shaolai Zhou,Jian Zhou,Liqing Zhu,Jixi Li
DOI: https://doi.org/10.1093/nar/gkae401
IF: 14.9
2024-05-25
Nucleic Acids Research
Abstract:Precise genomic editing through the combination of CRISPR/Cas systems and recombinant adeno-associated virus (rAAV)-delivered homology directed repair (HDR) donor templates represents a powerful approach. However, the challenge of effectively suppressing leaky transcription from the rAAV vector, a phenomenon associated to cytotoxicity, persists. In this study, we demonstrated substantial promoter activities of various homology arms and inverted terminal repeats (ITR). To address this issue, we identified a novel rAAV variant, Y704T, which not only yields high-vector quantities but also effectively suppresses in cis mRNA transcription driven by a robust promoter. The Y704T variant maintains normal functionality in receptor interaction, intracellular trafficking, nuclear entry, uncoating, and second-strand synthesis, while specifically exhibiting defects in transcription. Importantly, this inhibitory effect is found to be independent of ITR, promoter types, and RNA polymerases. Mechanistic studies unveiled the involvement of Valosin Containing Protein (VCP/p97) in capsid-mediated transcription repression. Remarkably, the Y704T variant delivers HDR donor templates without compromising DNA replication ability and homologous recombination efficiency. In summary, our findings enhance the understanding of capsid-regulated transcription and introduce novel avenues for the application of the rAAV-CRISPR/Cas9 system in human gene therapy.
biochemistry & molecular biology